321 related articles for article (PubMed ID: 3035114)
1. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
[TBL] [Abstract][Full Text] [Related]
2. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
[TBL] [Abstract][Full Text] [Related]
3. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
4. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Zagar I; Han R; Mitrovic S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
[TBL] [Abstract][Full Text] [Related]
5. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
[TBL] [Abstract][Full Text] [Related]
6. The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):3-8. PubMed ID: 9002740
[TBL] [Abstract][Full Text] [Related]
7. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
8. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
[TBL] [Abstract][Full Text] [Related]
9. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
Feldman JM; Blinder RA; Lucas KJ; Coleman RE
J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
[TBL] [Abstract][Full Text] [Related]
10. 131I-MIBG scintigraphy in neural crest tumours.
Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
[TBL] [Abstract][Full Text] [Related]
12. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
[TBL] [Abstract][Full Text] [Related]
13. 131I-MIBG therapy of neural crest tumours (review).
Troncone L; Rufini V
Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
[TBL] [Abstract][Full Text] [Related]
14. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
Skowsky WR; Wilf LH
South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
[TBL] [Abstract][Full Text] [Related]
15. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and therapy of neuroectodermal tumors].
Adolph J; Kimmig B
Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501
[TBL] [Abstract][Full Text] [Related]
17. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
[TBL] [Abstract][Full Text] [Related]
18. Multiple chemodectomas. Carotid body tumor masked by salivary gland uptake on I-123 MIBG scintigraphy.
Weissman AF; Gonzalez CE; Shapiro B; Shulkin B; Francis IR; Leach K
Clin Nucl Med; 1994 Jun; 19(6):527-31. PubMed ID: 8062474
[TBL] [Abstract][Full Text] [Related]
19. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
[TBL] [Abstract][Full Text] [Related]
20. Unsuccessful iodine-131 MIBG imaging of carcinoid tumors and apudomas.
Sinzinger H; Renner F; Granegger S
J Nucl Med; 1986 Jul; 27(7):1221-2. PubMed ID: 3723196
[No Abstract] [Full Text] [Related]
[Next] [New Search]